Protagonist Therapeutics (PTGX) EBIT Margin Growth (1y) (2018 - 2026)
Protagonist Therapeutics (PTGX) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | 6,171.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,171.00 |
| Dec 31, 2025 | -75,392.00 |
| Sep 30, 2025 | -9,847.00 |
| Jun 30, 2025 | 17,292.00 |
| Mar 31, 2025 | -14,910.00 |
| Dec 31, 2024 | 3,074.00 |
| Jun 30, 2022 | -346,112.00 |
| Mar 31, 2022 | 30,605.00 |
| Dec 31, 2021 | -9,630.00 |
| Sep 30, 2021 | -27,056.00 |
| Jun 30, 2021 | -107,042.00 |
| Mar 31, 2021 | 15,196.00 |
| Dec 31, 2020 | -109,973.00 |
| Sep 30, 2020 | 35,530.00 |
| Jun 30, 2020 | 9,051.00 |
| Mar 31, 2020 | 39,889.00 |
| Dec 31, 2019 | 142,145.00 |
| Sep 30, 2019 | -26,107.00 |
| Jun 30, 2019 | -30,438.00 |
| Mar 31, 2019 | -86,265.00 |